Total Payments
$736,098
2024 Payments
$59,125
Companies
22
Transactions
754
Medicare Patients
337
Medicare Billing
$37,937

Payment Breakdown by Category

Other$583,782 (79.3%)
Consulting$98,469 (13.4%)
Travel$37,065 (5.0%)
Food & Beverage$15,640 (2.1%)
Education$1,142 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $560,242 215 76.1%
Consulting Fee $98,469 39 13.4%
Travel and Lodging $37,065 85 5.0%
Food and Beverage $15,640 389 2.1%
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $13,240 2 1.8%
Honoraria $10,300 7 1.4%
Education $1,142 17 0.2%

Top Paying Companies

Company Total Records Latest Year
Biogen, Inc. $229,710 208 $0 (2024)
Genentech USA, Inc. $117,309 96 $0 (2024)
EMD Serono, Inc. $78,559 58 $0 (2024)
Novartis Pharmaceuticals Corporation $76,821 99 $0 (2023)
TG Therapeutics, Inc. $70,146 35 $0 (2024)
GENZYME CORPORATION $69,747 56 $0 (2023)
Celgene Corporation $39,156 33 $0 (2024)
Alexion Pharmaceuticals, Inc. $17,041 22 $0 (2021)
Teva Pharmaceuticals USA, Inc. $15,656 94 $0 (2019)
Horizon Therapeutics plc $10,680 18 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $59,125 49 TG Therapeutics, Inc. ($32,235)
2023 $113,452 74 TG Therapeutics, Inc. ($36,111)
2022 $109,341 65 Biogen, Inc. ($39,683)
2021 $51,789 35 Biogen, Inc. ($17,374)
2020 $49,514 48 Celgene Corporation ($24,014)
2019 $147,891 130 Novartis Pharmaceuticals Corporation ($42,628)
2018 $105,662 104 Biogen, Inc. ($42,666)
2017 $99,323 249 Biogen, Inc. ($48,326)

All Payment Transactions

754 individual payment records from CMS Open Payments — Page 1 of 31

Date Company Product Nature Form Amount Type
12/17/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,712.50 General
Category: Immunology
12/05/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $15.34 General
Category: Immunology
10/22/2024 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $24.86 General
Category: Neurology
09/26/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,712.50 General
Category: Immunology
09/23/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $16.93 General
Category: Neuroscience
09/18/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,712.50 General
Category: Immunology
09/18/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Immunology
09/13/2024 Biogen, Inc. VUMERITY (Drug) Consulting Fee Cash or cash equivalent $685.00 General
Category: Neurology
09/01/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $34.15 General
Category: Inflammation/Rare Disease
08/23/2024 EMD Serono, Inc. Mavenclad (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,243.00 General
Category: Neurology
08/15/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,712.50 General
Category: Immunology
08/15/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $24.89 General
Category: Immunology
08/13/2024 Biogen, Inc. TYSABRI (Biological) Food and Beverage In-kind items and services $22.40 General
Category: Neurology
08/10/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,712.50 General
Category: Immunology
07/31/2024 Genentech, Inc. Food and Beverage In-kind items and services $31.97 General
07/19/2024 Biogen, Inc. TYSABRI (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,055.00 General
Category: Neurology
07/18/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $21.74 General
Category: Inflammation/Rare Disease
06/17/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $19.74 General
Category: Neuroscience
06/13/2024 Biogen, Inc. VUMERITY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,055.00 General
Category: Neurology
05/24/2024 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $23.23 General
Category: Neurology
05/23/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $817.37 General
Category: Neurology
05/23/2024 EMD Serono, Inc. Mavenclad (Drug) Travel and Lodging Cash or cash equivalent $317.20 General
Category: Neurology
05/22/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $930.00 General
Category: Immunology
05/22/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $19.74 General
Category: Neuroscience
05/15/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,712.50 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 82 108 $25,596 $10,115
2022 2 77 100 $22,712 $9,110
2021 2 75 103 $22,739 $8,957
2020 3 103 132 $27,736 $9,755
Total Patients
337
Total Services
443
Medicare Billing
$37,937
Procedure Codes
8

All Medicare Procedures & Services

8 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 82 108 $25,596 $10,115 39.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 66 87 $20,619 $8,405 40.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 11 13 $2,093 $705.23 33.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 55 81 $19,197 $7,375 38.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 20 22 $3,542 $1,582 44.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 48 66 $15,642 $5,157 33.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 38 46 $7,406 $2,793 37.7%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 17 20 $4,688 $1,805 38.5%

About Dr. Mary Bailey, MD

Dr. Mary Bailey, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558543686.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mary Bailey, MD has received a total of $736,098 in payments from pharmaceutical and medical device companies, with $59,125 received in 2024. These payments were reported across 754 transactions from 22 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($560,242).

As a Medicare-enrolled provider, Bailey has provided services to 337 Medicare beneficiaries, totaling 443 services with total Medicare billing of $37,937. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.

Practice Information

Products in Payments

  • TECFIDERA (Drug) $79,597
  • OCREVUS (Biological) $77,897
  • BRIUMVI (Drug) $68,346
  • AUBAGIO (Drug) $63,023
  • VUMERITY (Drug) $49,650
  • TYSABRI (Biological) $45,907
  • ZEPOSIA (Drug) $40,263
  • Mavenclad (Drug) $37,607
  • MAVENCLAD (Drug) $27,096
  • Ocrevus (Biological) $18,791
  • MAYZENT (Drug) $18,304
  • COPAXONE (Drug) $15,069
  • Non-Covered Product (Drug) $12,806
  • UPLIZNA (Drug) $10,680
  • Ozanimod (Drug) $9,535
  • KESIMPTA (Drug) $8,616
  • GILENYA (Drug) $8,232
  • SOLIRIS (Drug) $6,821
  • Tysabri (Biological) $5,003
  • Mavenclad (Biological) $1,884

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in New Haven